<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1258" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1258/" /><meta name="ncbi_pagename" content="Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/04/04" /><meta name="citation_author" content="Marjo S van der Knaap" /><meta name="citation_author" content="Anne Fogli" /><meta name="citation_author" content="Odile Boespflug-Tanguy" /><meta name="citation_author" content="Truus EM Abbink" /><meta name="citation_author" content="Raphael Schiffmann" /><meta name="citation_pmid" content="20301435" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1258/" /><meta name="citation_keywords" content="CACH/VWM" /><meta name="citation_keywords" content="Leukoencephalopathy with Vanishing White Matter" /><meta name="citation_keywords" content="Leukoencephalopathy with Vanishing White Matter" /><meta name="citation_keywords" content="CACH/VWM" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit alpha" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit beta" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit delta" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit epsilon" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit gamma" /><meta name="citation_keywords" content="EIF2B1" /><meta name="citation_keywords" content="EIF2B2" /><meta name="citation_keywords" content="EIF2B3" /><meta name="citation_keywords" content="EIF2B4" /><meta name="citation_keywords" content="EIF2B5" /><meta name="citation_keywords" content="Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marjo S van der Knaap" /><meta name="DC.Contributor" content="Anne Fogli" /><meta name="DC.Contributor" content="Odile Boespflug-Tanguy" /><meta name="DC.Contributor" content="Truus EM Abbink" /><meta name="DC.Contributor" content="Raphael Schiffmann" /><meta name="DC.Date" content="2019/04/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1258/" /><meta name="description" content="Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) is characterized by ataxia, spasticity, and variable optic atrophy. The phenotypic range includes a prenatal/congenital form, a subacute infantile form (onset age &lt;1 year), an early childhood-onset form (onset age 1 to &lt;4 years), a late childhood-/juvenile-onset form (onset age 4 to &lt;18 years), and an adult-onset form (onset ≥18 years). The prenatal/congenital form is characterized by severe encephalopathy. In the later-onset forms initial motor and intellectual development is normal or mildly delayed, followed by neurologic deterioration with a chronic progressive or subacute course. While in childhood-onset forms motor deterioration dominates, in adult-onset forms cognitive decline and personality changes dominate. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illnesses or following head trauma or major surgical procedures, or by acute and extreme fright." /><meta name="og:title" content="Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter" /><meta name="og:type" content="book" /><meta name="og:description" content="Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) is characterized by ataxia, spasticity, and variable optic atrophy. The phenotypic range includes a prenatal/congenital form, a subacute infantile form (onset age &lt;1 year), an early childhood-onset form (onset age 1 to &lt;4 years), a late childhood-/juvenile-onset form (onset age 4 to &lt;18 years), and an adult-onset form (onset ≥18 years). The prenatal/congenital form is characterized by severe encephalopathy. In the later-onset forms initial motor and intellectual development is normal or mildly delayed, followed by neurologic deterioration with a chronic progressive or subacute course. While in childhood-onset forms motor deterioration dominates, in adult-onset forms cognitive decline and personality changes dominate. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illnesses or following head trauma or major surgical procedures, or by acute and extreme fright." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1258/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cach/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1258/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8827E8E0412DC10000000001390084.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1258_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1258_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cherubism/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cdp1-xlr/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1258_"><span class="title" itemprop="name">Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: CACH/VWM, Leukoencephalopathy with Vanishing White Matter</div><p class="contrib-group"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD, <span itemprop="author">Anne Fogli</span>, PhD, <span itemprop="author">Odile Boespflug-Tanguy</span>, MD, PhD, <span itemprop="author">Truus EM Abbink</span>, PhD, and <span itemprop="author">Raphael Schiffmann</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1258_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1258_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD<div class="affiliation small">Department of Child Neurology<br />VU University Medical Center<br />Amsterdam, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@paankrednav.sm" class="oemail">ln.cmuv@paankrednav.sm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anne Fogli</span>, PhD<div class="affiliation small">Genetics, Reproduction, and Development Unit<br />Faculty of Medicine<br />UMR INSERM 1103 CNRS 6293<br />Clermont-Ferrand, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.1tnomrelc-u.mresni@ilgof.enna" class="oemail">rf.1tnomrelc-u.mresni@ilgof.enna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Odile Boespflug-Tanguy</span>, MD, PhD<div class="affiliation small">Reference Center for Leukodystrophies<br />Department of Child Neurology<br />Robert Debr&#x000e9; University Hospital<br />University Paris Diderot - Sorbonne Cit&#x000e9;<br />UMR INSERM 676<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.phpa.bdr@yugnat-gulfpseob.elido" class="oemail">rf.phpa.bdr@yugnat-gulfpseob.elido</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Truus EM Abbink</span>, PhD<div class="affiliation small">Department of Child Neurology<br />VU University Medical Center<br />Amsterdam, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@knibba.g" class="oemail">ln.cmuv@knibba.g</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Raphael Schiffmann</span>, MD<div class="affiliation small">Institute of Metabolic Disease<br />Baylor Research Institute<br />Dallas, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htlaehrolyab@nnamffihcs.leahpar" class="oemail">ude.htlaehrolyab@nnamffihcs.leahpar</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 20, 2003</span>; Last Update: <span itemprop="dateModified">April 4, 2019</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cach.Summary" itemprop="description"><h2 id="_cach_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) is characterized by ataxia, spasticity, and variable optic atrophy. The phenotypic range includes a prenatal/<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> form, a subacute infantile form (onset age &#x0003c;1 year), an early childhood-onset form (onset age 1 to &#x0003c;4 years), a late childhood-/juvenile-onset form (onset age 4 to &#x0003c;18 years), and an adult-onset form (onset &#x02265;18 years). The prenatal/congenital form is characterized by severe encephalopathy. In the later-onset forms initial motor and intellectual development is normal or mildly delayed, followed by neurologic deterioration with a chronic progressive or subacute course. While in childhood-onset forms motor deterioration dominates, in adult-onset forms cognitive decline and personality changes dominate. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illnesses or following head trauma or major surgical procedures, or by acute and extreme fright.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CACH/VWM can be established in an individual with typical clinical findings, characteristic abnormalities on cranial MRI, and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of five genes (<i>EIF2B1</i>, <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, <i>EIF2B5</i>), which encode the five subunits of the eukaryotic translation initiation factor 2B (eIF2B).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Physical therapy and rehabilitation for motor dysfunction (mainly spasticity and ataxia); antiepileptic drugs for seizures.</p><p><i>Prevention of secondary complications</i>: Prevention of infections and fever when possible through the use of vaccinations, low-dose maintenance antibiotics during winter, antibiotics for minor infections, and antipyretics for fever. For children, wearing a helmet when outside helps minimize the effects of head trauma.</p><p><i>Surveillance</i>: Close monitoring of neurologic status for several days during febrile infections and following head trauma or surgical procedures with anesthesia.</p><p><i>Agents/circumstances to avoid</i>: Contact sports, head trauma, infections, high body temperature and, if possible, major surgery.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CACH/VWM is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variants in an affected relative have been identified.</p></div></div><div id="cach.Diagnosis"><h2 id="_cach_Diagnosis_">Diagnosis</h2><div id="cach.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) <b>should be suspected</b> in individuals with the following clinical, laboratory, and imaging findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Antenatal/early-infantile form:</div><ul><li class="half_rhythm"><div>Oligohydramnios</div></li><li class="half_rhythm"><div>Intrauterine growth retardation</div></li><li class="half_rhythm"><div>Severe encephalopathy</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Contractures</div></li><li class="half_rhythm"><div>Cataract</div></li><li class="half_rhythm"><div>Pancreatitis</div></li><li class="half_rhythm"><div>Hepatosplenomegaly</div></li><li class="half_rhythm"><div>Renal hypoplasia</div></li></ul></li><li class="half_rhythm"><div>Later-onset form:</div><ul><li class="half_rhythm"><div>Initial motor and intellectual development is normal or mildly delayed.</div></li><li class="half_rhythm"><div>Neurologic deterioration has a chronic progressive or subacute course. Episodes of subacute deterioration may follow minor infection or minor head trauma and may lead to lethargy or coma.</div></li><li class="half_rhythm"><div>Truncal and appendicular ataxia</div></li><li class="half_rhythm"><div>Spasticity with increased tendon reflexes</div></li><li class="half_rhythm"><div>Peripheral nervous system is usually not involved.</div></li><li class="half_rhythm"><div>Optic atrophy may develop.</div></li><li class="half_rhythm"><div>Epilepsy may occur but is not the predominant sign of the disease except in an acute situation.</div></li><li class="half_rhythm"><div>In children, intellectual abilities may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but not to the same degree as motor functions. Alteration in intellectual abilities associated with behavioral changes can be the initial symptom in adult-onset forms.</div></li><li class="half_rhythm"><div>Ovarian failure may be present as primary or secondary amenorrhea [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</div></li></ul></li></ul><p><b>Laboratory findings</b> [<a class="bk_pop" href="#cach.REF.van_der_knaap.1999.728">van der Knaap et al 1999</a>]</p><ul><li class="half_rhythm"><div>Routine cerebrospinal fluid (CSF) analysis is normal.</div></li><li class="half_rhythm"><div>Glycine is often elevated.</div></li></ul><p><b>MRI findings</b></p><ul><li class="half_rhythm"><div>The cerebral hemispheric white matter is symmetrically and diffusely abnormal.</div></li><li class="half_rhythm"><div>Part of the abnormal white matter has a signal intensity close to or the same as CSF on T<sub>1</sub>-weighted (<a class="figpopup" href="/books/NBK1258/figure/cach.Fa/?report=objectonly" target="object" rid-figpopup="figcachFa" rid-ob="figobcachFa">Figure 1</a>), T<sub>2</sub>-weighted (<a class="figpopup" href="/books/NBK1258/figure/cach.Fa/?report=objectonly" target="object" rid-figpopup="figcachFa" rid-ob="figobcachFa">Figure 2</a>), and fluid-attenuated inversion recovery (FLAIR) (<a class="figpopup" href="/books/NBK1258/figure/cach.Fa/?report=objectonly" target="object" rid-figpopup="figcachFa" rid-ob="figobcachFa">Figure 3</a>) images.</div></li><li class="half_rhythm"><div>On T<sub>1</sub>-weighted and FLAIR images, a fine meshwork of remaining tissue strands is usually visible within the areas of CSF-like white matter, with a typical radiating appearance on sagittal and coronal images and a dot-like pattern in the centrum semiovale on the transverse images (<a class="figpopup" href="/books/NBK1258/figure/cach.F4/?report=objectonly" target="object" rid-figpopup="figcachF4" rid-ob="figobcachF4">Figure 4</a>) [<a class="bk_pop" href="#cach.REF.van_der_knaap.2006.413">van der Knaap et al 2006</a>].</div></li><li class="half_rhythm"><div>The MRI abnormalities are present in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals regardless of age of onset and are even present in asymptomatic affected sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, although in presymptomatic and early symptomatic individuals the cerebral white matter may be abnormal on MRI, but not yet CSF-like. Over time, increasing amounts of white matter vanish and are replaced with CSF; cystic breakdown of the white matter is seen on proton density or FLAIR images [<a class="bk_pop" href="#cach.REF.van_der_knaap.2006.413">van der Knaap et al 2006</a>]. Cerebellar atrophy varies from mild to severe and primarily involves the vermis.</div></li><li class="half_rhythm"><div>Severe cerebral atrophy can be observed in adult-onset forms with slow progression. Cranial CT scan is of limited use and usually shows diffuse and symmetric hypodensity of the cerebral hemispheric white matter with no calcifications.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcachFa" co-legend-rid="figlgndcachFa"><a href="/books/NBK1258/figure/cach.Fa/?report=objectonly" target="object" title="Figure" class="img_link icnblk_img figpopup" rid-figpopup="figcachFa" rid-ob="figobcachFa"><img class="small-thumb" src="/books/NBK1258/bin/cach-Image001.gif" src-large="/books/NBK1258/bin/cach-Image001.jpg" alt="Image " /></a><div class="icnblk_cntnt" id="figlgndcachFa"><h4 id="cach.Fa"><a href="/books/NBK1258/figure/cach.Fa/?report=objectonly" target="object" rid-ob="figobcachFa">Figure</a></h4><p class="float-caption no_bottom_margin">MRI of an individual with the classic form of CACH/VWM Figure 1. Diffuse hypointensity of the white matter on T<sub>1</sub>-weighted images</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcachF4" co-legend-rid="figlgndcachF4"><a href="/books/NBK1258/figure/cach.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figcachF4" rid-ob="figobcachF4"><img class="small-thumb" src="/books/NBK1258/bin/cach-Image002.gif" src-large="/books/NBK1258/bin/cach-Image002.jpg" alt="Figure 4. . Parasagittal T1-weighted MRI image of an individual with CACH/VWM shows diffuse hypointensity of the white matter interrupted by a typical meshwork of remaining tissue strands radiating across the abnormal white matter." /></a><div class="icnblk_cntnt" id="figlgndcachF4"><h4 id="cach.F4"><a href="/books/NBK1258/figure/cach.F4/?report=objectonly" target="object" rid-ob="figobcachF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Parasagittal T<sub>1</sub>-weighted MRI image of an individual with CACH/VWM shows diffuse hypointensity of the white matter interrupted by a typical meshwork of remaining tissue strands radiating across the abnormal white matter. </p></div></div></div><div id="cach.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CACH/VWM <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above <a href="#cach.Suggestive_Findings">Suggestive Findings</a> and/or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK1258/table/cach.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcachTmoleculargenetictestingusedin" rid-ob="figobcachTmoleculargenetictestingusedin">Table 1</a> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of CACH/VWM is broad, individuals with the distinctive findings described in <a href="#cach.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#cach.Option_1">Option 1</a>), whereas those in whom the diagnosis of CACH/VWM has not been considered are more likely to be diagnosed using genomic testing (see <a href="#cach.Option_2">Option 2</a>).</p><div id="cach.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of CACH/VWM, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>; a panel that includes the genes listed in <a class="figpopup" href="/books/NBK1258/table/cach.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcachTmoleculargenetictestingusedin" rid-ob="figobcachTmoleculargenetictestingusedin">Table 1</a> and other genes of interest (see <a href="#cach.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="cach.Option_2"><h4>Option 2</h4><p>When the diagnosis of CACH/VWM is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cach.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter (CACH/VWM)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1258/table/cach.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cach.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of CACH/VWM Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>3</sup></th><th id="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> Detectable by Method</th></tr><tr><th headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></th><th headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B1</i></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.7%&#x000a0;<sup>3</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/9&#x000a0;<sup>7,&#x000a0;8,&#x000a0;9</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B2</i></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16.6%&#x000a0;<sup>3</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%%&#x000a0;<sup>7</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 10</td></tr><tr><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B3</i></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.8%&#x000a0;<sup>3</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/22&#x000a0;<sup>7,&#x000a0;9,&#x000a0;11</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B4</i></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.4%&#x000a0;<sup>3</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31/31&#x000a0;<sup>7,&#x000a0;9,&#x000a0;10</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B5</i></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">66.5%&#x000a0;<sup>3</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%&#x000a0;<sup>7</sup></td><td headers="hd_h_cach.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_cach.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cach.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="cach.TF.1.2"><p class="no_margin">See <a href="/books/NBK1258/#cach.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="cach.TF.1.3"><p class="no_margin">All or almost all individuals with CACH/VWM have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants identified in one of the five associated genes [<a class="bk_pop" href="#cach.REF.maletkovic.2008.205">Maletkovic et al 2008</a>, <a class="bk_pop" href="#cach.REF.van_der_knaap.2010">van der Knaap et al 2010</a>, <a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p></div></dd><dt>4. </dt><dd><div id="cach.TF.1.4"><p class="no_margin">See <a href="#cach.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>5. </dt><dd><div id="cach.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="cach.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="cach.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#cach.REF.maletkovic.2008.205">Maletkovic et al [2008]</a>, <a class="bk_pop" href="#cach.REF.shimada.2015.960">Shimada et al [2015]</a>, <a class="bk_pop" href="#cach.REF.zhang.2015.e0118001">Zhang et al [2015]</a></p></div></dd><dt>8. </dt><dd><div id="cach.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#cach.REF.alamri.2016.717">Alamri et al [2016]</a></p></div></dd><dt>9. </dt><dd><div id="cach.TF.1.9"><p class="no_margin">This number reflects the number of unique variants reported. Some variants are recurrent (see <a href="#cach.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>10. </dt><dd><div id="cach.TF.1.10"><p class="no_margin">A single multigene <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> including <i>EIF2B2</i> has been reported [<a class="bk_pop" href="#cach.REF.shimada.2012.1771">Shimada et al 2012</a>].</p></div></dd><dt>11. </dt><dd><div id="cach.TF.1.11"><p class="no_margin"><a class="bk_pop" href="#cach.REF.gowda.2017.196">Gowda et al [2017]</a>, <a class="bk_pop" href="#cach.REF.song.2017.867">Song et al [2017]</a></p></div></dd><dt>12. </dt><dd><div id="cach.TF.1.12"><p class="no_margin"><a class="bk_pop" href="#cach.REF.kanbayashi.2015.401">Kanbayashi et al [2015]</a>, <a class="bk_pop" href="#cach.REF.lynch.2017.1204">Lynch et al [2017]</a>, <a class="bk_pop" href="#cach.REF.hettiaracchchi.2018.2731039">Hettiaracchchi et al [2018]</a></p></div></dd></dl></div></div></div><p><b>Incidental findings*</b></p><ul><li class="half_rhythm"><div><b>Eukaryotic translation initiation factor 2B (eIF2B) guanine exchange factor (GEF) activity</b> measured in lymphoblastoid cell lines from <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals was found to be lower in most persons with pathogenic variants in <i>EIF2B1</i>, <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, or <i>EIF2B5</i> than in control subjects [<a class="bk_pop" href="#cach.REF.fogli.2004b.561">Fogli et al 2004b</a>]. eIF2B GEF activity assays in lymphoblastoid cell lines from 63 affected persons presenting with different clinical forms and pathogenic variants <i>EIF2B1</i>, <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, or <i>EIF2B5</i> showed significantly decreased GEF activity with 100% specificity and 89% <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> when the activity threshold was set at 77.5% of normal [<a class="bk_pop" href="#cach.REF.horzinski.2009.e8318">Horzinski et al 2009</a>]. In the early-infantile form of the disease (onset age &#x0003c;1 year) the GEF activity was below the threshold of 77.5% of normal. Persons with late-onset disease and a wide variety of pathogenic variants (<a class="figpopup" href="/books/NBK1258/table/cach.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcachTmoleculargenetictestingusedin" rid-ob="figobcachTmoleculargenetictestingusedin">Table 1</a>) had higher GEF activity that overlapped with the normal range. A significant decrease of GEF activity has also been reported in the 8/8 <i>EIF2B1-5</i>-mutated lymphoblastoid cell lines and 3/4 fibroblast cell lines analyzed by <a class="bk_pop" href="#cach.REF.liu.2011.1036">Liu et al [2011]</a>. However, no correlation between eIF2B GEF activity and disease severity was found in this study. The findings were substantiated by similar results in transfected HEK293 cells [<a class="bk_pop" href="#cach.REF.liu.2011.1036">Liu et al 2011</a>]. Thus, it can be concluded that if decreased activity is found, CACH/VWM is the most likely diagnosis; but if normal or increased activity is found, CACH/VWM cannot be ruled out.</div></li><li class="half_rhythm"><div><b>The CSF glycine level</b> was found to be elevated in persons with CACH/VWM, in whom the diagnosis was later molecularly confirmed [<a class="bk_pop" href="#cach.REF.van_der_knaap.1999.728">van der Knaap et al 1999</a>]. This test is not specific and its <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> is not known.</div></li><li class="half_rhythm"><div><b>The CSF asialotransferrin/total transferrin ratio</b> was found to be low in persons with genetically confirmed CACH/VWM, a finding that can help identify those likely to have pathogenic variants in any of the five genes encoding the eIF2B subunits detected on <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> [<a class="bk_pop" href="#cach.REF.vanderver.2005.2031">Vanderver et al 2005</a>]. Note: This test is cumbersome and not generally available.</div></li></ul><p>* Testing is on a research basis only.</p></div></div></div><div id="cach.Clinical_Characteristics"><h2 id="_cach_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cach.Clinical_Description"><h3>Clinical Description</h3><p>Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) phenotypes range from a <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early-infantile form (onset age &#x0003c;1 year) to an early childhood-onset form (onset age 1 to &#x0003c;4 years), a late-childhood/juvenile-onset form (onset age 4 to &#x0003c;18 years), and an adult-onset form (onset &#x02265;18 years [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. Both the childhood and juvenile forms have been observed in sibs; the infantile and juvenile/adult forms have never been observed within the same family [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p><p><b>Neurology.</b> The neurologic signs depend on the age of onset [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. In the <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and early-infantile forms, the encephalopathy is severe, seizures are often a predominant clinical feature, and decline is rapid and followed quickly by death. In early and late childhood-onset forms, motor decline predominates with ataxia and spasticity. Cognitive decline is relatively mild. Adult-onset forms usually present with cognitive decline and mood and personality changes; motor decline comes later in the disease course. Optic atrophy is variable and rather late in all forms.</p><p>The rate of disease progression depends on the age of onset. For individuals with disease onset before age four years, the decline is in general more rapid and more severe the earlier the onset. For onset after age four years, the disease course is generally slower and milder and life span is longer. For this later-onset group, however, variation in severity is wide and does not correlate with specific age at onset [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illness or following minor head trauma or fright; such exacerbations are more common in early-onset than in later-onset forms of the disease [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. Rarely, a child or an adult with normal neurologic examination and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK1258/table/cach.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcachTmoleculargenetictestingusedin" rid-ob="figobcachTmoleculargenetictestingusedin">Table 1</a> is identified by brain MRI that is performed because of headache or dizziness [<a class="bk_pop" href="#cach.REF.fontenelle.2008.549">Fontenelle et al 2008</a>]. Follow up of such individuals for more than ten years may show no neurologic deterioration [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>; R Schiffmann, unpublished data].</p><p><b>Ovarian failure.</b> While the juvenile and adult forms are often associated with primary or secondary ovarian failure &#x02013; a syndrome referred to as "ovarioleukodystrophy" [<a class="bk_pop" href="#cach.REF.schiffmann.1997.654">Schiffmann et al 1997</a>, <a class="bk_pop" href="#cach.REF.fogli.2003.1544">Fogli et al 2003</a>], ovarian failure may occur in any of the forms regardless of age of onset; it has been found at autopsy in infantile and childhood cases [<a class="bk_pop" href="#cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</a>]. Because the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals were prepubertal, the ovarian dysgenesis was not clinically manifest.</p><p><b>Antenatal form.</b> The antenatal-onset form presents in the third trimester of pregnancy with oligohydramnios and decreased fetal movement [<a class="bk_pop" href="#cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</a>, <a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. Clinical features that may be noted soon after birth include feeding difficulties, vomiting, hypotonia, mild contractures, cataract (sometimes oil droplet cataract), and microcephaly. Apathy, intractable seizures, and finally apneic spells and coma follow. Other organ involvement can include hepatosplenomegaly, renal hypoplasia, pancreatitis, and ovarian dysgenesis.</p><p>The clinical course is rapidly and relentlessly downhill; the adverse effect of stress factors is less clear. So far, all infants with neonatal presentation have died within the first year of life [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p><p><b>Infantile form.</b> A rapidly fatal severe form of CACH/VWM is characterized by onset in the first year of life and death a few months later [<a class="bk_pop" href="#cach.REF.fogli.2002.506">Fogli et al 2002</a>, <a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].] Affected infants develop irritability, stupor, and rapid loss of motor abilities, with or without a preceding intercurrent infection.</p><p>A specific infantile-onset <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was described as "Cree leukoencephalopathy" because of its occurrence in the native North American Cree and Chippewayan indigenous population [<a class="bk_pop" href="#cach.REF.fogli.2002.506">Fogli et al 2002</a>]. Infants typically have hypotonia followed by sudden onset of seizures (age 3-6 months), spasticity, vomiting (often with fever), developmental regression, blindness, lethargy, and cessation of head growth, with death by age two years.</p><p><b>Early childhood-onset form.</b> Initially most children develop normally; some have mild motor or speech delay. New-onset ataxia is the most common initial symptom between ages one and four years. Some children develop dysmetric tremor or become comatose spontaneously or acutely following mild head trauma or febrile illness [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p><p>Subsequently, generally progressive deterioration results in increasing difficulty in walking, tremor, spasticity with hyperreflexia, dysarthria, and seizures. Once a child becomes nonambulatory, the clinical course may remain stable for several years. Swallowing difficulties and optic atrophy develop late in the disease.</p><p>Head circumference is usually normal; however, severe progressive macrocephaly occurring after age two years has been reported [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]; microcephaly has also been observed. The peripheral nervous system is usually normal, although predominantly sensory nerve involvement has been reported [<a class="bk_pop" href="#cach.REF.federico.2006.353">Federico et al 2006</a>, <a class="bk_pop" href="#cach.REF.huntsman.2007.766">Huntsman et al 2007</a>]. Intellectual abilities are relatively preserved.</p><p>The time course of disease progression varies among individuals even within the same family, ranging from rapid progression with death occurring one to five years after onset to very slow progression with death occurring decades after onset.</p><p><b>Late childhood/juvenile-onset form.</b> Children develop symptoms between ages four and 18 years. They often have a slowly progressive spastic diplegia, relative sparing of cognitive ability, and likely long-term survival with long periods of stability and even temporary improvement of motor function [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. However, the disease course is highly variable and rapid progression and death after a few months have also been described [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p><p><b>Adult-onset form.</b> Behavioral problems associated with cognitive decline are frequently reported before neurologic symptoms appear [<a class="bk_pop" href="#cach.REF.labauge.2009.2161">Labauge et al 2009</a>, <a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. Acute, transient neurologic symptoms (optic neuritis, hemiparesis) or severe headache &#x02013; as well as primary or secondary amenorrhea in females &#x02013; can be the presenting symptoms.</p><p>Asymptomatic and minimally symptomatic adults with two pathogenic variants in one of the genes and a typically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sib have also been described [<a class="bk_pop" href="#cach.REF.leegwater.2001.383">Leegwater et al 2001</a>, <a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p><p><b>Neuropathologic findings</b> in general are a cavitating orthochromatic leukodystrophy with rarity of myelin breakdown and relative sparing of axons [<a class="bk_pop" href="#cach.REF.bugiani.2010.987">Bugiani et al 2010</a>]. Vacuolization and cavitation of the white matter are diffuse, giving a spongiform appearance. Cerebral and cerebellar myelin is markedly diminished. The spinal cord is also <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#cach.REF.leferink.2018.862">Leferink et al 2018</a>]. Oligodendrocytes are increased in number, whereas astrogliosis is feeble [<a class="bk_pop" href="#cach.REF.bugiani.2011.69">Bugiani et al 2011</a>]. The hallmark is the presence of oligodendrocytes with "foamy" cytoplasm and markedly abnormal astrocytes with few stunted processes [<a class="bk_pop" href="#cach.REF.wong.2000.635">Wong et al 2000</a>, <a class="bk_pop" href="#cach.REF.bugiani.2011.69">Bugiani et al 2011</a>]. The white matter astrocytes and oligodendrocytes are immature and are, in fact, astrocyte and oligodendrocyte precursor cells, explaining the lack of myelin production and scarce gliosis [<a class="bk_pop" href="#cach.REF.bugiani.2011.69">Bugiani et al 2011</a>, <a class="bk_pop" href="#cach.REF.bugiani.2013.209">Bugiani et al 2013</a>].</p></div><div id="cach.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>No statistically significant differences have been observed for individuals with pathogenic variants in <i>EIF2B1, EIF2B2, EIF2B3, EIF2B4,</i> or <i>EIF2B5</i> regarding age of onset and survival [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. Only for the parameter "loss of walking without support," an overall significant difference was observed: ambulation was better preserved in individuals with <i>EIF1B1</i> pathogenic variants, but this group was very small (only five individuals) and therefore not necessarily representative; when excluding these five individuals from the analysis, no overall differences remained for individuals with pathogenic variants in <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, or <i>EIF2B5</i> [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p></div><div id="cach.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Although <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> exists, correlation between certain <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants and age of onset and disease severity has been described [<a class="bk_pop" href="#cach.REF.fogli.2004a.1509">Fogli et al 2004a</a>, <a class="bk_pop" href="#cach.REF.van_der_lei.2010.1555">van der Lei et al 2010</a>, <a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>]. A recent study of 296 individuals with CACH/VWM compared all available groups of at least three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from different families with the same pathogenic variants. In most groups with a similar <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>, severity measures, such as age of onset and survival, were rather consistent, but some variability was present, especially for pathogenic variants associated with a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b><i>EIF2B5</i></b></p><ul><li class="half_rhythm"><div>In individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object" rid-figpopup="figcachTchildhoodataxiawithcentralner" rid-ob="figobcachTchildhoodataxiawithcentralner">p.Thr91Ala</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may vary from childhood onset to adults with no symptoms [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</div></li><li class="half_rhythm"><div>Certain <i>EIF2B5</i> <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants, such as <a class="figpopup" href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object" rid-figpopup="figcachTchildhoodataxiawithcentralner" rid-ob="figobcachTchildhoodataxiawithcentralner">p.Arg113His</a>, are most often (though not invariably) associated with a mild disease form and never give rise to the infantile type [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</div></li><li class="half_rhythm"><div>Certain <i>EIF2B5</i> pathogenic variants, such as those at p.Arg339 (<a class="figpopup" href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object" rid-figpopup="figcachTchildhoodataxiawithcentralner" rid-ob="figobcachTchildhoodataxiawithcentralner">p.Arg339Trp</a>, <a class="figpopup" href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object" rid-figpopup="figcachTchildhoodataxiawithcentralner" rid-ob="figobcachTchildhoodataxiawithcentralner">p.Arg339Gln</a>, or <a class="figpopup" href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object" rid-figpopup="figcachTchildhoodataxiawithcentralner" rid-ob="figobcachTchildhoodataxiawithcentralner">p.Arg339Pro</a>) and <a class="figpopup" href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object" rid-figpopup="figcachTchildhoodataxiawithcentralner" rid-ob="figobcachTchildhoodataxiawithcentralner">p.Val309Leu</a>, are predictably associated with severe disease [<a class="bk_pop" href="#cach.REF.leegwater.2001.383">Leegwater et al 2001</a>, <a class="bk_pop" href="#cach.REF.fogli.2004a.1509">Fogli et al 2004a</a>, <a class="bk_pop" href="#cach.REF.van_der_lei.2010.1555">van der Lei et al 2010</a>].</div></li></ul></div><div id="cach.Penetrance"><h3>Penetrance</h3><p>Some adults who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for two disease-causing pathogenic variants in the same <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> may be asymptomatic for prolonged periods of time [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>].</p></div><div id="cach.Nomenclature"><h3>Nomenclature</h3><p>"Cree leukoencephalopathy," described in the native North American Cree and Chippewayan indigenous population, is now recognized to be an infantile form of CACH/VWM [<a class="bk_pop" href="#cach.REF.fogli.2002.506">Fogli et al 2002</a>].</p></div><div id="cach.Prevalence"><h3>Prevalence</h3><p>The prevalence of CACH/VWM is not known; it is considered one of the more common leukodystrophies. In the Netherlands, the live-birth incidence was recently shown to be 1:80,000 [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>] and the prevalence of known, living <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is 1.4:1,000,000.</p></div></div><div id="cach.Genetically_Related_Allelic_Disorde"><h2 id="_cach_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>Thus far, all individuals with eIF2B-related disease have a leukodystrophy; no other phenotypes have been observed.</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> that included <i>EIF2B2</i> and an additional <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>EIF2B2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were reported in a child with features of CACH/VWM plus <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features [<a class="bk_pop" href="#cach.REF.shimada.2012.1771">Shimada et al 2012</a>].</p></div><div id="cach.Differential_Diagnosis"><h2 id="_cach_Differential_Diagnosis_">Differential Diagnosis</h2><div id="cach.T.other_disorders_affecting_the_whi" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Disorders Affecting the White Matter Diffusely During Childhood to Consider in the Differential Diagnosis of CACH/VWM</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1258/table/cach.T.other_disorders_affecting_the_whi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cach.T.other_disorders_affecting_the_whi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing MRI findings</th></tr></thead><tbody><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AARS2</i>-related ovarioleukodystrophy</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AARS2</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Extensive or diffuse cerebral WM changes</div></li><li class="half_rhythm"><div>Involvement of the corpus callosum connecting lesions on both sides</div></li><li class="half_rhythm"><div>Involvement of long descending tracts</div></li></ul></td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood cerebral form of <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCD1</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Extensive or diffuse cerebral WM changes but, as a rule, no cystic degeneration</td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mld/">Arylsulfatase A deficiency</a> (metachromatic leukodystrophy)</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSA</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/krabbe/">Krabbe disease</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALC</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/canavan/">Canavan disease</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ASPA</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alexander/">Alexander disease</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFAP</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>WM signal changes have a frontal predominance.</div></li><li class="half_rhythm"><div>The cystic degeneration may affect the subcortical or deep WM.</div></li><li class="half_rhythm"><div>Basal ganglia &#x00026; thalamic abnormalities are frequently present.</div></li><li class="half_rhythm"><div>Contrast enhancement of characteristic structures often facilitates diagnosis.</div></li></ul></td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mlc/">Megalencephalic leukoencephalopathy with subcortical cysts</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HEPACAM</i><br /><i>MLC1</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD&#x000a0;<sup>1</sup></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Diffusely abnormal &#x00026; mildly swollen cerebral hemispheric WM that does not show signs of diffuse rarefaction or cystic degeneration</div></li><li class="half_rhythm"><div>Subcortical cysts are almost always present in the anterior temporal area &#x00026; often in other regions.</div></li><li class="half_rhythm"><div>Cysts are best seen on proton density &#x00026; FLAIR.</div></li></ul></td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-overview/">Mitochondrial leukoencephalopathies</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR<br />mt</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MRI abnormalities may be similar to those seen in CACH/VWM, but WM cysts are typically well delineated (in contrast to CACH/VWM).</div></li><li class="half_rhythm"><div>Prominent &#x00026; diffuse WM rarefaction &#x00026; cystic degeneration may be seen in mitochondrial disorders.</div></li></ul></td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmd/"><i>PLP1-</i>related disorders</a><br />(Pelizaeus Merzbacher disease &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> spastic paraplegia 2)</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLP1</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Diffuse hyperintensity of WM on T<sub>2</sub>-weighted images is also observed in leukodystrophies w/primary hypomyelination (e.g., <i>PLP1</i>-related disorders), but these disorders have a normal or nearly normal WM signal on T<sub>1</sub>-weighted images &#x00026; CT scan.</div></li><li class="half_rhythm"><div>There is no WM rarefaction of cystic degeneration.</div></li><li class="half_rhythm"><div>In addition, central nerve conduction evaluated w/evoked potentials is always severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> even at an early stage of the disease.</div></li></ul></td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cadasil/">CADASIL</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH3</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Consider these disorders in those w/adult-onset CACH/VWM; however, the early constant diffuse symmetric alteration of WM on MRI in eIF2B-related disorders is distinctive.</td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lad-ad/">Autosomal dominant leukodystrophy with autonomic disease</a></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNB1</i></td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acquired white matter disorders such as multiple sclerosis</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_cach.T.other_disorders_affecting_the_whi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CACH/VWM = childhood ataxia with central nervous system / hypomyelination / vanishing white matter; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; mt = mitochondrial; WM = white matter; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="cach.TF.2.1"><p class="no_margin">Biallelic pathogenic variants in <i>MLC1</i> or <i>HEPACAM</i> are causative of classic megalencephalic leukoencephalopathy with subcortical cysts (MLC1 or MLC2A, respectively); <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HEPACAM</i> pathogenic variants are causative of MLC2B. MLC1 and MLC2A are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. MLC2B is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div></dd><dt>2. </dt><dd><div id="cach.TF.2.2"><p class="no_margin">Mitochondrial diseases are a clinically heterogeneous group of disorders that can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA).</p></div></dd><dt>3. </dt><dd><div id="cach.TF.2.3"><p class="no_margin">See <a href="https://omim.org/phenotypicSeries/PS126200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Phenotypic Series: Multiple sclerosis, susceptibility to</a> for a list of genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd><dt>4. </dt><dd><div id="cach.TF.2.4"><p class="no_margin">Available data suggest that multiple sclerosis is inherited as a complex <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a> disorder that results from the interaction of genetic and environmental factors.</p></div></dd></dl></div></div></div></div><div id="cach.Management"><h2 id="_cach_Management_">Management</h2><div id="cach.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Physical therapy/occupational therapy assessment as needed</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>Note: If an individual is diagnosed while asymptomatic, either because of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sib or as an incidental finding on <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, the above evaluations and the recommendations in <a href="#cach.Prevention_of_Secondary_Complicatio">Prevention of Secondary Complications</a> should be applied.</p></div><div id="cach.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Physical therapy and rehabilitation for motor dysfunction (mainly spasticity and ataxia)</div></li><li class="half_rhythm"><div>Ankle-foot orthotics in individuals with hypotonia and weakness of ankle dorsiflexors</div></li><li class="half_rhythm"><div>Antiepileptic drugs for treatment of seizures and abnormalities of behavior and mood</div></li></ul></div><div id="cach.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Considering the known adverse effect of fever, it is important to prevent infections and fever as much as possible (e.g., through the use of vaccinations, including anti-flu vaccination); low-dose maintenance antibiotics during winter time, antibiotics for minor infections, and antipyretics for fever are appropriate. For children, wearing a helmet while outside helps minimize the effects of possible head trauma.</p></div><div id="cach.Surveillance"><h3>Surveillance</h3><p>Close surveillance for several days following head trauma or major surgical procedure with anesthesia is indicated because neurologic deterioration (presumably stress related) may follow.</p></div><div id="cach.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Contact sports and other activities with a high risk of head trauma</div></li><li class="half_rhythm"><div>Stressful emotional and physical situations (e.g., acute fright, fever and other causes of extreme temperatures, major surgery)</div></li></ul></div><div id="cach.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#cach.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cach.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="cach.Other"><h3>Other</h3><p>In general, corticosteriods and intravenous gamma globulin are not effective in the treatment of CACH/VWM. Corticosteriods have been used with inconsistent results in acute situations, including intractable status epilepticus.</p></div></div><div id="cach.Genetic_Counseling"><h2 id="_cach_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cach.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cach.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one CACH/VWM-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in carriers of pathogenic variants in <i>EIF2B1</i>, <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, or <i>EIF2B5.</i></div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Age of onset of neurologic signs can differ from one individual to another within the same family. Therefore, a neurologically asymptomatic sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants and be at high risk of developing the disease. The large majority (if not all) of apparently asymptomatic individuals appear to have the extensive white matter abnormalities characteristic of the syndrome on head MRI, and may have very mild learning, cognitive, or behavioral disabilities. Note: Although both the childhood and juvenile forms have been observed in sibs [<a class="bk_pop" href="#cach.REF.leegwater.2001.383">Leegwater et al 2001</a>], the infantile and juvenile/adult forms have never been observed within the same family [<a class="bk_pop" href="#cach.REF.hamilton.2018.274">Hamilton et al 2018</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in carriers of a CACH/VWM-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a><i>.</i></div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with CACH/VWM are obligate heterozygotes (carriers) for a CACH/VWM-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a CACH/VWM-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cach.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the CACH/VWM-causing pathogenic variants in the family.</p></div><div id="cach.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and to young adults who are affected or at risk, or are carriers.</div></li></ul><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk individuals is possible once the CACH/VWM-causing pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li><li class="half_rhythm"><div>Predictive testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cach.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the CACH/VWM-causing pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cach.Resources"><h2 id="_cach_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=leukoencephalopathywithvanishingwhitematter" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leukoencephalopathy with vanishing white matter</a></div></li><li class="half_rhythm"><div><b>European Leukodystrophy Association (ELA)</b></div><div>2, rue Mi-les-Vignes</div><div>B.P. 61024</div><div>Laxou Cedex 54521</div><div>France</div><div><b>Phone:</b> 03833093 34</div><div><b>Fax:</b> 03833000 68</div><div><b>Email:</b> ela@ela-asso.com</div><div><a href="http://www.ela-asso.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ela-asso.com</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="cach.Molecular_Genetics"><h2 id="_cach_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cach.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1258/table/cach.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cach.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cach.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cach.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cach.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cach.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cach.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cach.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cach.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1967" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EIF2B1</i></a></td><td headers="hd_b_cach.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1967" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q24<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14232" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Translation initiation factor eIF-2B subunit alpha</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EIF2B1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B1 database</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EIF2B1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B1</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EIF2B1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B1</a></td></tr><tr><td headers="hd_b_cach.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8892" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EIF2B2</i></a></td><td headers="hd_b_cach.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8892" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P49770" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Translation initiation factor eIF-2B subunit beta</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EIF2B2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B2 database</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EIF2B2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B2</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EIF2B2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B2</a></td></tr><tr><td headers="hd_b_cach.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8891" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EIF2B3</i></a></td><td headers="hd_b_cach.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8891" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p34<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NR50" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Translation initiation factor eIF-2B subunit gamma</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EIF2B3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B3 database</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EIF2B3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B3</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EIF2B3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B3</a></td></tr><tr><td headers="hd_b_cach.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8890" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EIF2B4</i></a></td><td headers="hd_b_cach.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8890" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UI10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Translation initiation factor eIF-2B subunit delta</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EIF2B4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B4 database</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EIF2B4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B4</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EIF2B4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B4</a></td></tr><tr><td headers="hd_b_cach.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8893" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EIF2B5</i></a></td><td headers="hd_b_cach.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8893" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q27<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13144" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Translation initiation factor eIF-2B subunit epsilon</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EIF2B5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B5 database</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EIF2B5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B5</a></td><td headers="hd_b_cach.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EIF2B5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EIF2B5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cach.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cach.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter (<a href="/omim/603896,603945,606273,606454,606686,606687" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1258/table/cach.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cach.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603896" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603896</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603945" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603945</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606273" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606273</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606454" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606454</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606686" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606686</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606687" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606687</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4</td></tr></tbody></table></div></div><div id="cach.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b> The eukaryotic translation initiation factor eIF2B is composed of five subunits. Its function is to convert protein synthesis initiation factor 2 (eIF2) from an inactive GDP-bound form to an active eIF2-GTP complex, allowing the formation of the 43S complex, needed for initiation of <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> translation. It is not yet understood why a defect in eIF2B, a ubiquitous protein complex, affects predominantly the brain white matter. The crucial role of eIF2B as regulator of protein synthesis under stress conditions could explain the neurologic deterioration during or after head trauma and fever [<a class="bk_pop" href="#cach.REF.scheper.2006.159">Scheper et al 2006</a>].</p><p>The biologic importance of the eIF2B complex is evidenced by the following:</p><ul><li class="half_rhythm"><div>Yeast with <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> pathogenic variants for any of the five genes <i>EIF2B1</i>-<i>EIF2B5</i> is not viable.</div></li><li class="half_rhythm"><div>Pathogenic variants that completely abolish eIF2B activity are probably lethal in the biallellic state in humans; <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants are rare and only observed in compound heterozygotes in association with a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant [<a class="bk_pop" href="#cach.REF.van_der_knaap.2010">van der Knaap et al 2010</a>].</div></li><li class="half_rhythm"><div>Affected individuals have decreased GEF activity (20%-77% of normal) [<a class="bk_pop" href="#cach.REF.fogli.2004b.561">Fogli et al 2004b</a>, <a class="bk_pop" href="#cach.REF.horzinski.2009.e8318">Horzinski et al 2009</a>].</div></li><li class="half_rhythm"><div>Pathogenic variants in <i>EIF2B1</i>-<i>EIF2B5</i> that decrease guanine exchange factor (GEF) activity result from aberrant protein folding, leading to an impaired ability to form functional eIF2B complexes that bind substrate normally [<a class="bk_pop" href="#cach.REF.li.2004.3295">Li et al 2004</a>, <a class="bk_pop" href="#cach.REF.richardson.2004.2352">Richardson et al 2004</a>].</div></li></ul><p>Of note, decreased GEF activity leads to enhanced translation of specific <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> of proteins, similar to the situation that occurs when a cell is under stress.</p><p><b>Mechanism of disease causation.</b> All disease-associated variants are <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants, hampering eIF2B activity, thus impairing cell stress responses.</p><div id="cach.T.childhood_ataxia_with_central_ner" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter: Notable Pathogenic Variants by Gene</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1258/table/cach.T.childhood_ataxia_with_central_ner/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cach.T.childhood_ataxia_with_central_ner_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B2</i></td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_014239.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014239<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_055054.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055054<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.638A&#x0003e;G</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu213Gly</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dutch <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, associated w/relatively mild disease [<a class="bk_pop" href="#cach.REF.leegwater.2001.383">Leegwater et al 2001</a>]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B3</i></td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020365.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020365<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_065098.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_065098<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.260C&#x0003e;T</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala87Val</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">French-Canadian (non-Cree) <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#cach.REF.robinson.2014.225">Robinson et al 2014</a>]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1037T&#x0003e;C</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile346Thr</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chinese <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#cach.REF.zhang.2015.e0118001">Zhang et al 2015</a>]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B5</i></td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_2" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003907.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003907<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_003898.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003898<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.271A&#x0003e;G</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr91Ala</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dutch <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, associated w/relatively mild disease [<a class="bk_pop" href="#cach.REF.leegwater.2001.383">Leegwater et al 2001</a>]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.337C&#x0003e;T</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg113His</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, associated w/relatively mild disease [<a class="bk_pop" href="#cach.REF.leegwater.2001.383">Leegwater et al 2001</a>]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.584G&#x0003e;A</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg195His</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, associated w/severe disease [<a class="bk_pop" href="#cach.REF.fogli.2002.506">Fogli et al 2002</a>]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.925G&#x0003e;C</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val309Leu</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant associated w/severe disease Fogli et al 2004a]</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1015C&#x0003e;T</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg339Trp</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_5" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">All reported variants at this position are associated w/severe disease [<a class="bk_pop" href="#cach.REF.van_der_lei.2010.1555">van der Lei et al 2010</a>].</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1016G&#x0003e;A</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg339Gln</td></tr><tr><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1016G&#x0003e;C</td><td headers="hd_h_cach.T.childhood_ataxia_with_central_ner_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg339Pro</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cach.TF.3.1"><p class="no_margin">Genes are in alphabetic order.</p></div></dd></dl></div></div></div></div></div><div id="cach.References"><h2 id="_cach_References_">References</h2><div id="cach.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cach.REF.alamri.2016.717">Alamri H, Al Mutairi F, Alothman J, Alothaim A, Alfadhel M, Alfares A. Diabetic ketoacidosis in vanishing white matter. <span><span class="ref-journal">Clin Case Rep. </span>2016;<span class="ref-vol">4</span>:717–20.</span> [<a href="/pmc/articles/PMC4974412/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4974412</span></a>] [<a href="/pubmed/27525068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27525068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.bugiani.2010.987">Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS. Leukoencephalopathy with vanishing white matter: a review. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2010;<span class="ref-vol">69</span>:987–96.</span> [<a href="/pubmed/20838246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20838246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.bugiani.2011.69">Bugiani M, Boor I, van Kollenburg B, Postma N, Polder E, van Berkel C, van Kesteren RE, Windrem MS, Hol EM, Scheper GC, Goldman SA, van der Knaap MS. Defective glial maturation in vanishing white matter disease. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2011;<span class="ref-vol">70</span>:69–82.</span> [<a href="/pmc/articles/PMC4135437/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4135437</span></a>] [<a href="/pubmed/21157376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21157376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.bugiani.2013.209">Bugiani M, Postma N, Polder E, Dieleman N, Scheffer PG, Sim FJ, van der Knaap MS, Boor I. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:209–22.</span> [<a href="/pubmed/23365098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23365098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.federico.2006.353">Federico A, Scali O, Stromillo ML, Di Perri C, Bianchi S, Sicurelli F, De Stefano N, Malandrini A, Dotti MT. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:353–5.</span> [<a href="/pubmed/16864840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16864840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.fogli.2003.1544">Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O. Ovarian failure related to eukaryotic initiation factor 2B mutations. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1544–50.</span> [<a href="/pmc/articles/PMC1180314/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180314</span></a>] [<a href="/pubmed/12707859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707859</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.fogli.2004a.1509">Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O. The effect of genotype on the natural history of eIF2B-related leukodystrophies. <span><span class="ref-journal">Neurology. </span>2004a;<span class="ref-vol">62</span>:1509–17.</span> [<a href="/pubmed/15136673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15136673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.fogli.2004b.561">Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. <span><span class="ref-journal">Eur J Hum Genet. </span>2004b;<span class="ref-vol">12</span>:561–6.</span> [<a href="/pubmed/15054402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15054402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.fogli.2002.506">Fogli A, Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:506–10.</span> [<a href="/pubmed/12325082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12325082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.fontenelle.2008.549">Fontenelle LM, Scheper GC, Brandao L, van der Knaap MS. Atypical presentation of vanishing white matter disease. <span><span class="ref-journal">Arq Neuropsiquiatr. </span>2008;<span class="ref-vol">66</span>:549–51.</span> [<a href="/pubmed/18813718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18813718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.gowda.2017.196">Gowda VK, Srinivasan VM, Bhat M, Benakappa A. Case of childhood ataxia with central nervous system hypomyelination with a novel mutation in EIF2B3 gene. <span><span class="ref-journal">J Pediatr Neurosci. </span>2017;<span class="ref-vol">12</span>:196–8.</span> [<a href="/pmc/articles/PMC5588653/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5588653</span></a>] [<a href="/pubmed/28904586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28904586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.hamilton.2018.274">Hamilton EMC, van der Lei HDW, Vermeulen G, Gerver JAM, Louren&#x000e7;o CM, Naidu S, Mierzewska H, Gemke RJBJ, de Vet HCW, Uitdehaag BMJ, Lissenberg-Witte BI, van der Knaap MS, et al.  The natural history of vanishing white matter. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">84</span>:274–88.</span> [<a href="/pmc/articles/PMC6175238/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6175238</span></a>] [<a href="/pubmed/30014503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30014503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.hettiaracchchi.2018.2731039">Hettiaracchchi D, Neththikumara N, Pathirana BAPS, Padeniya A, Dissanayake VHW. A novel mutation in the EIF2B4 gene associated with leukoencephalopathy with vanishing white matter. <span><span class="ref-journal">Case Rep Pediatr. </span>2018;<span class="ref-vol">2018</span>:2731039.</span> [<a href="/pmc/articles/PMC6057309/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6057309</span></a>] [<a href="/pubmed/30073106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30073106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.horzinski.2009.e8318">Horzinski L, Huyghe A, Cardoso MC, Gonthier C, Ouchchane L, Schiffmann R, Blanc P, Boespflug-Tanguy O, Fogli A. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e8318.</span> [<a href="/pmc/articles/PMC2789406/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2789406</span></a>] [<a href="/pubmed/20016818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20016818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.huntsman.2007.766">Huntsman RJ, Seshia S, Lowry N, Lemire EG, Harder SL. Peripheral neuropathy in a child with Cree leukodystrophy. <span><span class="ref-journal">J Child Neurol. </span>2007;<span class="ref-vol">22</span>:766–8.</span> [<a href="/pubmed/17641267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17641267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.kanbayashi.2015.401">Kanbayashi T, Saito F, Matsukawa T, Oba H, Hokkoku K, Hatanaka Y, Tsuji S, Sonoo M. Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">88</span>:401–3.</span> [<a href="/pubmed/25600065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25600065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.labauge.2009.2161">Labauge P, Horzinski L, Ayrignac X, Blanc P, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de S&#x000e8;ze J, Fogli A, Boespflug-Tanguy O. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:2161–9.</span> [<a href="/pubmed/19625339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19625339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.leegwater.2001.383">Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:383–8.</span> [<a href="/pubmed/11704758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11704758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.leferink.2018.862">Leferink PS, Breeuwsma N, Bugiani M, van der Knaap MS, Heine VM. Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter. <span><span class="ref-journal">Glia. </span>2018;<span class="ref-vol">66</span>:862–873.</span> [<a href="/pmc/articles/PMC5838785/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5838785</span></a>] [<a href="/pubmed/29285798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29285798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.li.2004.3295">Li W, Wang X, van der Knaap MS, Proud CG. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. <span><span class="ref-journal">Mol Cell Biol. </span>2004;<span class="ref-vol">24</span>:3295–306.</span> [<a href="/pmc/articles/PMC381664/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC381664</span></a>] [<a href="/pubmed/15060152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15060152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.liu.2011.1036">Liu R, van der Lei HD, Wang X, Wortham NC, Tang H, van Berkel CG, Mufunde TA, Huang W, van der Knaap MS, Scheper GC, Proud CG. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:1036–45.</span> [<a href="/pubmed/21560189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21560189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.lynch.2017.1204">Lynch DS, Rodrigues Brand&#x000e3;o de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, Hughes D, Pittman A, Laur&#x000e0; M, Reilly MM, Warren JD, Mummery CJ, Schott JM, Adams M, Fox NC, Murphy E, Davagnanam I, Kok F, Chataway J, Houlden H. Clinical and genetic characterization of leukoencephalopathies in adults. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:1204–11.</span> [<a href="/pmc/articles/PMC5405235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5405235</span></a>] [<a href="/pubmed/28334938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28334938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.maletkovic.2008.205">Maletkovic J, Schiffmann R, Gorospe F, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR, Singhal BS, Harding C, Amartino H, Brown CM, Chan A, Renaud D, Geraghty M, Jensen L, Senbil N, Kadom N, Nazarian J, Feng Y, Wang Z, Hartka T, Morizono H, Vanderver A. Genetic and clinical heterogeneity in eIF2B-related disorder. <span><span class="ref-journal">J Child Neurol. </span>2008;<span class="ref-vol">23</span>:205–15.</span> [<a href="/pubmed/18263758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18263758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.richardson.2004.2352">Richardson JP, Mohammad SS, Pavitt GD. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity. <span><span class="ref-journal">Mol Cell Biol. </span>2004;<span class="ref-vol">24</span>:2352–63.</span> [<a href="/pmc/articles/PMC355856/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC355856</span></a>] [<a href="/pubmed/14993275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14993275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.robinson.2014.225">Robinson M&#x000c8;, Rossignol E, Brais B, Rouleau G, Arbour JF, Bernard G. Vanishing white matter disease in French-Canadian patients from Quebec. <span><span class="ref-journal">Pediatr Neurol. </span>2014;<span class="ref-vol">51</span>:225–32.</span> [<a href="/pubmed/25079571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25079571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.scheper.2006.159">Scheper GC, Proud CG, van der Knaap MS. Defective translation initiation causes vanishing of cerebral white matter. <span><span class="ref-journal">Trends Mol Med. </span>2006;<span class="ref-vol">12</span>:159–166.</span> [<a href="/pubmed/16545608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16545608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.schiffmann.1997.654">Schiffmann R, Tedeschi G, Kinkel RP, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L, Yanovski JA. Leukodystrophy in patients with ovarian dysgenesis. <span><span class="ref-journal">Ann Neurol. </span>1997;<span class="ref-vol">41</span>:654–61.</span> [<a href="/pubmed/9153528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9153528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.shimada.2012.1771">Shimada S, Miya K, Oda N, Watanabe Y, Kumada T, Sugawara M, Shimojima K, Yamamoto T. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease. <span><span class="ref-journal">Am J Med Genet. </span>2012;<span class="ref-vol">158A</span>:1771–7.</span> [<a href="/pubmed/22678813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22678813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.shimada.2015.960">Shimada S, Shimojima K, Sangu N, Hoshino A, Hachiya Y, Ohto T, Hashi Y, Nishida K, Mitani M, Kinjo S, Tsurusaki Y, Matsumoto N, Morimoto M, Yamamoto T. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. <span><span class="ref-journal">Brain Dev. </span>2015;<span class="ref-vol">37</span>:960–6.</span> [<a href="/pubmed/25843247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25843247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.song.2017.867">Song H, Haeri S, Vogel H, van der Knaap M, Van Haren K. Postmortem whole exome sequencing identifies novel EIF2B3 mutation with prenatal phenotype in 2 siblings. <span><span class="ref-journal">J Child Neurol. </span>2017;<span class="ref-vol">32</span>:867–70.</span> [<a href="/pubmed/28597716" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28597716</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.van_der_knaap.2010">van der Knaap MS, Bugiani M, Boor I, Proud CG, Scheper GC. Vanishing white matter. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson KM, Mitchell G, eds. <em>Online Metabolic and Molecular Bases of Inherited Disease.</em> Chap 235.1. New York:McGraw-Hill. 2010.</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.van_der_knaap.2006.413">van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. <span><span class="ref-journal">Lancet Neurol. </span>2006;<span class="ref-vol">5</span>:413–23.</span> [<a href="/pubmed/16632312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16632312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.van_der_knaap.2003.1199">van der Knaap MS, van Berkel CG, Herms J, van Coster R, Baethmann M, Naidu S, Boltshauser E, Willemsen MA, Plecko B, Hoffmann GF, Proud CG, Scheper GC, Pronk JC. eIF2B-related disorders: antenatal onset and involvement of multiple organs. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">73</span>:1199–207.</span> [<a href="/pmc/articles/PMC1180499/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180499</span></a>] [<a href="/pubmed/14566705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14566705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.van_der_knaap.1999.728">van der Knaap MS, Wevers RA, Kure S, Gabre&#x000eb;ls FJM, Verhoeven NM, van Raaij-Selten B, Jaeken J. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencepohalopathy with vanishing white matter. <span><span class="ref-journal">J Child Neurol. </span>1999;<span class="ref-vol">14</span>:728–31.</span> [<a href="/pubmed/10593550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10593550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.van_der_lei.2010.1555">van der Lei HD, van Berkel CG, van Wieringen WN, Brenner C, Feigenbaum A, Mercimek-Mahmutoglu S, Philippart M, Tatli B, Wassmer E, Scheper GC, van der Knaap MS. Genotype-phenotype correlation in vanishing white matter disease. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:1555–9.</span> [<a href="/pubmed/20975056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20975056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.vanderver.2005.2031">Vanderver A, Schiffmann R, Timmons M, Kellersberger KA, Fabris D, Hoffman EP, Maletkovic J, Hathout Y. Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination / vanishing white matter disease. <span><span class="ref-journal">Clin Chem. </span>2005;<span class="ref-vol">51</span>:2031–42.</span> [<a href="/pubmed/16155092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16155092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.wong.2000.635">Wong K, Armstrong RC, Gyure KA, Morrison AL, Rodriguez D, Matalon R, Johnson AB, Wollmann R, Gilbert E, Le TQ, Bradley CA, Crutchfield K, Schiffmann R. Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>2000;<span class="ref-vol">100</span>:635–46.</span> [<a href="/pubmed/11078215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11078215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cach.REF.zhang.2015.e0118001">Zhang H, Dai L, Chen N, Zang L, Leng X, Du L, Wang J, Jiang Y, Zhang F, Wu X, Wu Y. Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. <span><span class="ref-journal">PLoS One. </span>2015;<span class="ref-vol">10</span>:e0118001.</span> [<a href="/pmc/articles/PMC4356545/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4356545</span></a>] [<a href="/pubmed/25761052" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25761052</span></a>]</div></li></ul></div></div><div id="cach.Chapter_Notes"><h2 id="_cach_Chapter_Notes_">Chapter Notes</h2><div id="cach.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 April 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 August 2012 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> for this disorder now listed in the GeneTests&#x02122; Laboratory Directory</div></li><li class="half_rhythm"><div>24 May 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 February 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 July 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 February 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>19 November 2002 (pb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1258</span><span class="label">PMID: <a href="/pubmed/20301435" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301435</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cherubism/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cdp1-xlr/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1258&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1258/?report=reader">PubReader</a></li><li><a href="/books/NBK1258/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1258" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1258" style="display:none" title="Cite this Page"><div class="bk_tt">van der Knaap MS, Fogli A, Boespflug-Tanguy O, et al. Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter. 2003 Feb 20 [Updated 2019 Apr 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1258/pdf/Bookshelf_NBK1258.pdf">PDF version of this page</a> (574K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cach.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cach.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cach.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cach.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cach.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cach.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cach.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cach.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cach.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cach.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cach.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8892[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EIF2B2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8893[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EIF2B5</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8891[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EIF2B3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8890[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EIF2B4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1967[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EIF2B1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1475652" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1475652" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1475652" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1475652" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24501781" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25758335" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.</a><span class="source">[Am J Med Genet A. 2015]</span><div class="brieflinkpop offscreen_noflow">Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Woody AL, Hsieh DT, McIver HK, Thomas LP, Rohena L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2015 Apr; 167A(4):826-30. Epub 2015 Mar 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16998732" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The spectrum of mutations for the diagnosis of vanishing white matter disease.</a><span class="source">[Neurol Sci. 2006]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The spectrum of mutations for the diagnosis of vanishing white matter disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scali O, Di Perri C, Federico A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Sci. 2006 Sep; 27(4):271-7. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25457085" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.</a><span class="source">[Brain Dev. 2015]</span><div class="brieflinkpop offscreen_noflow">A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Takano K, Tsuyusaki Y, Sato M, Takagi M, Anzai R, Okuda M, Iai M, Yamashita S, Okabe T, Aida N, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Dev. 2015 Jun; 37(6):638-42. Epub 2014 Oct 27.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16246171" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The large spectrum of eIF2B-related diseases.</a><span class="source">[Biochem Soc Trans. 2006]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The large spectrum of eIF2B-related diseases.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Fogli A, Boespflug-Tanguy O. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Biochem Soc Trans. 2006 Feb; 34(Pt 1):22-9. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301435" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301435" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04157bdde0891169020cb5">Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White M...</a><div class="ralinkpop offscreen_noflow">Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:05:47-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE8827E8E0412DC10000000001390084&amp;ncbi_session=CE8827E8E04157A1_0313SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1258%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1258&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1258/&amp;ncbi_pagename=Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8827E8E04157A1_0313SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>